TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05076786

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chidamide
Description: 20mg, administered orally. Week 1/2: twice a week (d0, d4, d7, d11); Week 3: stop. Repeat every 3 weeks for 4-6 cycles.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide + Cisplatin/Carboplatin
Description: Etoposide (100mg/m2; intravenous infusion; d1-3) + Cisplatin (75mg/m2; intravenous infusion; d1). Repeat every 3 weeks for 4-6 cycles.~OR Etoposide (100mg/m2; intravenous infusion; d1-3) + Cisplatin (25mg/m2; intravenous infusion; d1-3). Repeat every 3 weeks for 4-6 cycles.~OR Etoposide (100mg/m2; intravenous infusion; d1-3) + Carboplatin (AUC=5; intravenous infusion; d1). Repeat every 3 weeks for 4-6 cycles.
Study: NCT05573048

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Trans-Perineal Grid
Description: A small square piece of plastic with many holes in it placed between the legs to help guide the path of the interventional instruments and to facilitate the prostate intervention. The guide grid will help with needle placement using the grid technology.
Study: NCT06030570

Intervention type: OTHER
Intervention: Rehabilitation program (Revita)
Description: Multidisciplinary programs in an outpatient hospital setting are coordinated by specialists in Physical and Rehabilitation Medicine. These programs combine a physical part (e.g., specific exercises, manual techniques) with at least one other element (psychological, social, educational or occupational intervention). In a multidisciplinary spine rehabilitation program, a maximum of 36 sessions over a maximum time period of 6 months is offered. Afterwards, a (monodisciplinary) follow-up trajectory (K15) is possible, consisting of maximum 104 sessions a year.
Study: NCT06226389

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: 4 different bulk-fill composite
Description: Posterior cavities either class 1/2

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: 4 different bulk-fill composite
Description: Posterior cavities either class 1/2
Study: NCT06291818

Intervention type: DEVICE
Group type: OTHER
Intervention: temporary magnetic system for tarsorrhaphy (MST)
Description: cutting-edge technology has produced smaller magnets with stronger magnetic fields, prompting experts to revisit the use of magnets to facilitate eyelid closure
Study: NCT04851405

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Otago Exercise Programme+ (OEP+)
Description: Physiotherapists (PTs) will receive OEP and BAP training. They will provide at home visits and follow-up phone calls to the older adult participants (5 at home visits and 3 phone calls).~Older adults will have access to the OEP app.

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Otago Exercise Programme (OEP)
Description: PTs will receive OEP training. They will provide at home visits and follow-up phone calls to the older adult participants (5 at home visits and 3 follow-up phone calls).
Study: NCT05815875

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: STEADI Program
Description: The investigators will conduct STEADI Algorithm for Falls Prevention educational sessions for healthcare providers in the neurosurgery unit, including doctors, nurses, physical therapists, and pharmacists. All healthcare providers in the neurosurgery unit will be invited to attend the educational sessions. Their participation will be voluntary and no obligations will be made, though. Healthcare providers will be invited to attend one 2-hour educational session. In each session, The investigators will have between 8-10 healthcare providers. The educational sessions will be delivered in the classroom available in the neurosurgery unit to facilitate the healthcare providers' access. PowerPoint presentations, videos, quizzes, case studies, and in-class discussions will be used to deliver learning content during the educational sessions. Healthcare providers will then be asked to apply the STEADI interventions on a group of patients.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Routine care
Description: The control group participants will receive routine care. Routine care involves only assessing for falls using Morse Falls Scale (MFS). MFS assesses a patient's fall risk upon admission, following a change in status, and at discharge or transfer to a new setting.
Study: NCT05180396

Intervention type: OTHER
Intervention: Questionnaires
Description: Application of a study based questionnaire described in the protocol
Study: NCT06348290

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JMKX001899
Description: Oral

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JMKX001899
Description: Oral

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JMKX001899
Description: Oral

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Itraconazole
Description: Oral

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam
Description: Oral

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rifampin
Description: Oral

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dextromethorphan
Description: Oral

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Description: Oral

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: digoxin
Description: Oral
Study: NCT06196671

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: H101
Description: H101 15x10\^11vp intratumorally injection starts at day 1.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camrelizumab
Description: Camrelizumab will be administered at 200 mg i.v. every 3 weeks at day 2.
Study: NCT05917678

Intervention type: OTHER
Group type: OTHER
Intervention: Repositioning Therapy
Description: Caregivers will be instructed how to increase tummy time activities and reshape their infant's heads using at-home methods to direct their attention to the non-preferred side.

Intervention type: OTHER
Group type: OTHER
Intervention: Repositioning Therapy
Description: Caregivers will be instructed how to increase tummy time activities and reshape their infant's heads using at-home methods to direct their attention to the non-preferred side.

Intervention type: DEVICE
Group type: OTHER
Intervention: Cranial Remolding Orthosis
Description: A custom cranial remolding orthosis (FDA Class II device) will be made to fit affected infants. this should be worn 23 hours per day and the Orthotist needs to be seen regularly for adjustments until the head shape is resolved.
Study: NCT06359444

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Combined aerobic + strength training
Description: Participants will follow a combination of endurance and strength training for 14 weeks.~There will be three sessions every week: two at Ghent university department of rehabilitation and one at home. Each session will last approximately one hour.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Combined strength + HIIT training
Description: 6 weeks of endurance training and strength training, 8 weeks of strength training and HIIT.~Participants will follow the same combination of endurance and strength training for the first six weeks, to build up to a baseline level of physical fitness. They will then switch to eight weeks of a combination of strength training and High Intensity Interval Training (HIIT).~There will be three sessions every week: two at Ghent university department of rehabilitation and one at home. Each session will last approximately one hour.
Study: NCT06058000

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 1.5% QLM3003
Description: QLM3003 topical cream

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 2% QLM3003
Description: QLM3003 topical cream

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 2% QLM3003
Description: QLM3003 topical cream

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle (Placebo)
Description: Vehicle topical cream

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle (Placebo)
Description: Vehicle topical cream
Study: NCT05877742

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: AA group
Description: Participants will individually receive a 5-minute AA education delivered verbally at his/her respective clinic by a trained nursing student interventionist in addition to the usual scheduled follow-ups and activities at clinics.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control group
Description: To mimic the time and attention spent, the control group will individually receive a 5-minute seminar delivered by an RA.
Study: NCT05165693

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental Formula
Description: Diabetes-specific study formula

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Test Meal
Description: Instant oatmeal
Study: NCT05909657

Intervention type: OTHER
Intervention: questionnaires (surveys)
Description: Mixed-methods study. Both the qualitative interview guides and the questionnaire surveys are adapted from the Sickle Cell Disease Implementation Consortium (SCDIC) project which is a multicentre study occurring in the United States.

Intervention type: OTHER
Intervention: questionnaires (surveys)
Description: Mixed-methods study. Both the qualitative interview guides and the questionnaire surveys are adapted from the Sickle Cell Disease Implementation Consortium (SCDIC) project which is a multicentre study occurring in the United States.

Intervention type: OTHER
Intervention: questionnaires (surveys)
Description: Mixed-methods study. Both the qualitative interview guides and the questionnaire surveys are adapted from the Sickle Cell Disease Implementation Consortium (SCDIC) project which is a multicentre study occurring in the United States.
Study: NCT06099730

Intervention type: DEVICE
Group type: OTHER
Intervention: Pulsed Field Ablation (PFA)
Description: PFA using Irreversible Electroporation (IRE) Ablation System
Study: NCT05231512

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Respiratory Music Therapy Protocol
Description: Participants will engage in eight (8) 45-minute virtual music therapy groups containing up to 6 participants over the course of 8 weeks. Within these groups, participants will be invited to use instruments provided including a Yamaha recorder and a Grover Trophy slide whistle. 45 minute virtual music therapy sessions facilitated by board-certified music therapy will consist of music-assisted relaxation through music visualization, followed by gentle pulmonary exercise via wind instrumental playing, and concluding with group singing.
Study: NCT05766878

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: implants placement
Description: The intervention will consist of placement of two types of short implants (one with traditional machined collar and one with anodized collar). After their healing period, the prosthetic rehabilitation will be made.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: implants placement
Description: The intervention will consist of placement of two types of short implants (one with traditional machined collar and one with anodized collar). After their healing period, the prosthetic rehabilitation will be made.
Study: NCT04791306

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: supervised exercise training
Description: Participates perform once a week for 4 months an in-house supervised endurance and strength training.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: home-based exercise training
Description: Participants are provided with an application for planning and documentation of their physical activity, together with an expert participants plan their physical activities for their home-based training to reach at least 150 min physical activity per week.
Study: NCT05189353

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ghrelin
Description: Ghrelin infusion

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Ghrelin
Description: Ghrelin infusion

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Saline infusion

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Saline infusion
Study: NCT06357676

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study: NCT05982340

Intervention type: DIAGNOSTIC_TEST
Intervention: Lithium clearance
Description: Blood and urine samples

Intervention type: DIAGNOSTIC_TEST
Intervention: Lithium clearance
Description: Blood and urine samples
Study: NCT06357676

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Biopsy
Description: Undergo bone marrow biopsy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT scan or FDG PET/CT

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Echocardiography
Description: Undergo echocardiography

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: FDG-Positron Emission Tomography
Description: Undergo FDG PET/CT

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Glofitamab
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibrutinib
Description: Given PO

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Obinutuzumab
Description: Given IV
Study: NCT05982340

Intervention type: DIAGNOSTIC_TEST
Intervention: Lithium clearance
Description: Blood and urine samples
Study: NCT05664984

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 1-face-to-face
Description: The cognitive rehabilitation intervention consists of 45-minute sessions, 2 days a week for 12 weeks. The same rehabilitation intervention program was applied to both groups by face-to-face or tele-rehabilitation method. The main purpose of the study is to see the effectiveness of cognitive rehabilitation intervention in the elderly with amnestic mild cognitive impairment and to compare the two methods.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 2-tele rehabilitation
Description: 2-tele rehabilitation
Study: NCT04560088

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness
Description: Mindfulness-based mobile health intervention.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Breathing
Description: Breathing mobile health intervention.
Study: NCT05522166

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Digital Stories and Face-to-face Basic Life Support Trainings
Description: In this study, digital storytelling and face-to-face applied techniques will be given to teacher candidates via social media (Whatsapp) and the impact of these trainings on the knowledge and skill levels of teacher candidates will be evaluated comparatively.
Study: NCT06237894

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multisensory Stimulation
Description: Multisensory Stimulation
Study: NCT04625127

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Treadmill gait training with GaitBetter
Description: Participants will receive gait training with the GaitBetter solution for a total of 15 sessions (3 days a week for 5 weeks) each lasting approximately 45 minutes.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Treadmill gait training with GaitBetter + Standard of care
Description: Participants will receive gait training with the GaitBetter solution for a total of 15 sessions (3 days a week for 5 weeks) each lasting approximately 45 minutes. In addition, the investigators will record the number and duration of therapy sessions followed by the participant during standard of care.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard of care
Description: Participants will follow their standard of care. The investigators will record the number and duration of therapy sessions followed during standard of care.
Study: NCT06549959

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Telitacicept Pre-filled Injection 80mg
Description: The patient received one treatment of Telitacicept 80mg in the test group
Study: NCT04880291

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: GFB-024
Description: Peripherally acting Cannabinoid-1 receptor inverse agonist monoclonal antibody

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: GFB-024
Description: Peripherally acting Cannabinoid-1 receptor inverse agonist monoclonal antibody

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matched placebo

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matched placebo
Study: NCT04765267

Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Zinc sulphate heptahydrate
Description: Dietary supplements

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Zinc sulphate heptahydrate
Description: Dietary supplements

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Zinc sulphate heptahydrate
Description: Dietary supplements
Study: NCT06392399

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: cooled radiofrequency ,
Description: In Cooled RF, after placement of the introducer needle, the 18 gauge internally cooled RF electrode is used for 90 seconds at a temperature of 60°C.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: conventional radiofrequency
Description: In conventional RF group lesion will be performed at 80°C for 120 seconds.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: neurolysis of ganglion
Description: In neurolytic block, Once the position of the needle tip confirmed, 4 - 6 mL of 8% phenol in saline will be injected followed by 1 mL of saline to avoid the deposition of phenol within the intervertebral disc material.
Study: NCT05202340

Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study: NCT05126251

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tangningtongluo tablet
Description: Tangningtongluo Tablet is an in-hospital preparation of Guizhou bailing. It is used for diabetes caused by deficiency of Qi and Yin. The symptoms include thirst, drinking, overeating, polyuria, weight loss, shortness of breath, fatigue, hand, foot and heart heat and blurred vision; Type 2 diabetes and diabetic retinopathy see the above syndrome. The present study shows that Tangningtongluo Tablet have certain hypoglycemic effects in diabetic animal models and diabetic patients, and may improve insulin sensitivity in diabetic mice.It is speculated that the drug may be effective for prediabetes. (0.4g/tablet,Plate(12 pills/plate ×3 plates/box))

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: lifestyle intervention
Description: Avoid overeating, avoid large intake of high-calorie, high-fat foods, live a regular life, avoid sitting for a long time, strengthen exercise and reduce weight.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: lifestyle intervention
Description: Avoid overeating, avoid large intake of high-calorie, high-fat foods, live a regular life, avoid sitting for a long time, strengthen exercise and reduce weight.
Study: NCT06426589

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Resistence training and mediterranean diet
Description: Resistance training. Subjects assigned to the experimental group participated in resistance program twice a week (on Tuesdays and Thursdays) for a period of 12 weeks, totaling 24 sessions of 60 minutes each. Each session during this time was divided into three clearly differentiated parts: i) 5-minute warm-up comprised of a series of gentle, low-intensity exercises designed to gradually prepare the muscles and joints of older adults for the main exercise.~Mediterranean Diet. In addition to the resistance intervention, the experimental group received a Mediterranean diet protocol based on the study by Ismail et al. \[34\] with the following meal plan: i) carbohydrates constituted 50% of daily intake; ii) fats repre-sented 35%; and iii) proteins accounted for 15%.
Study: NCT04119830

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Given IV

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rintatolimod
Description: Given IV
Study: NCT04870580

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Fluorodopa PET tracer
Description: PET/CT scan using fluorodopa tracer
Study: NCT05409534

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Backward Walking (Exercise group)
Description: The participant will apply a maximum of 40-50 minutes of exercise, including 10 minutes of warm-up exercise, 30 minutes of backward walking training and 10 minutes of cooling-off exercise. The maximum time to do backward walking training will be 30 minutes. In the backward walking exercise, 1 set will take 5 minutes. The maximum number of sets that can be made will be 6 sets. No more than 6 sets will be made.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Forward Walking (Control Group)
Description: The participant will apply a maximum of 40-50 minutes of exercise, including 10 minutes of warm-up exercise, 30 minutes of forward walking training and 10 minutes of cooling-off exercise as the home exercise programme.
Study: NCT05646017

Intervention type: DEVICE
Intervention: Intermittenly scanned continuous glucose monitoring
Description: Use of Intermittenly scanned continuous glucose monitoring (FreeStyle Libre)
Study: NCT05949502

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Beautifil II LS (Low-Shrinkage)
Description: low shrinkage bioactive material Giomer

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 3M Filtek Z250 XT Universal
Description: Universal Nano-hybrid composite
Study: NCT05254847

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine combined with lenvatinib and tislelizumab
Description: Capecitabine combined with lenvatinib and tislelizumab
Study: NCT05526040

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Immunonutrient-enriched oral nutrition supplementation
Description: Individualized dietary assessment and counselling with additional high energy, high protein, immunonutrient-enriched oral nutrition supplement; taken 3 servings per day, from 1 week prior to cancer treatment and continued throughout the cancer treatment.~Oral Impact® is an oral nutrition supplement product enriched with arginine (3.3g/sachet), omega-3 fatty acids (0.8g/sachet) and nucleotides (0.3g/sachet). The immunonutrient-enriched formula is also a complete and balanced formula, and is gluten free. The osmolality of the formula is 620 mOsm/kg water.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Standard medical nutrition therapy
Description: Individualized dietary assessment and counselling and standard nutrition supplementation via oral nutrition supplementation or enteral nutrition as necessary.
Study: NCT06549959

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Telitacicept Freeze-dried powder Injection 80mg
Description: The patient received one treatment of Telitacicept 80mg in the test group
Study: NCT05657574

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D377
Description: oral, once daily, 8 weeks